DTwP-HebB-Hib vaccine - Shantha Biotechnics

Drug Profile

DTwP-HebB-Hib vaccine - Shantha Biotechnics

Alternative Names: Diphtheria, Tetanus, Pertussis, Haemophilus influenza B, and Hepatitis B vaccine - Shantha Biotechnics; Hib-DTP-hepatitis-B vaccine - Shantha Biotechnics; Pentavalent vaccine - Shantha Biotechnics; Shan 5; Shan5

Latest Information Update: 22 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shantha Biotechnics
  • Class Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 05 May 2014 Shan5™ receives WHO prequalification status for the prevention of Diptheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B
  • 31 Mar 2014 Registered for Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention) in India (IM)
  • 03 Sep 2012 Phase-III clinical trials in Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top